Genomic Vision Stock Soars 23% In 10 Sessions: What’s Driving The Surge?

(VIANEWS) – Genomic Vision (GV.PA) shares experienced an astounding surge of 23.46% over 10 trading sessions, from EUR0.01 to EUR0.01 as of 16:15 EST Monday afternoon – after four consecutive sessions of losses. Meanwhile, France’s CAC 40 index currently trades at EUR7,313.32, up 0.23% after three declines consecutively. About GENOMIC VISION Genomic Vision Societe Anonyme…

Read More

CELYAD ONCOLOGY Slumps 9% As Market Ends Session: Is Trouble Brewing?

(VIANEWS) – CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell 9.81% to EUR0.96 at 15:18 EST Monday afternoon after four straight sessions of gains, while the BEL 20 was down 0.35% at EUR3,670.13, signalling an overall downward trend for today’s trading session. About CELYAD ONCOLOGY Celyad Oncology SA is a clinical-stage biopharmaceutical company focused on the research…

Read More